Allarity Therapeutics (ALLR) Stock: Buy, Sell, or Hold?
ALLR - Allarity Therapeutics, Inc. Common Stock
$1.07
0.03 (2.88%)
▲
5d:
+3.88%
30d:
-24.11%
90d:
-10.83%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When ALLR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ALLR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ALLR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ALLR is currently trading at $1.07, which is considered slightly low relative to its 30-day fair value range of $1.07 to $1.37.
Technical Outlook: Technically, ALLR is in a downtrend. Immediate support is located at $0.90, while resistance sits at $1.23.
Market Sentiment: ALLR scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $11.00 (+957.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ALLR is in a downtrend. Immediate support is located at $0.90, while resistance sits at $1.23.
Market Sentiment: ALLR scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $11.00 (+957.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.07 -
$1.37
Company Quality Score
66/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 957.7% below Wall St target ($11.00)
- CAUTION: Bottoming setup, but lagging the sector by 38% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$1.07 -
$1.37
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.90
Resistance Level
$1.23
Current Trend
Downtrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.21
Wall Street Target
$11.00
(+957.7%)
Share & Embed Analysis
Last updated: October 02, 2026 10:00 AM ET
Data refreshes hourly during market hours. Next update: 11:00 AM
Data refreshes hourly during market hours. Next update: 11:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALLR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 59 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 73 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 61 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 44 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 62 BUY |
